Abstract
The combination of adriamycin, 5-fluorouracil and methotrexate with folinic acid reversal was used to treat patients with advanced bronchogenic carcinoma. Twenty-one of 30 patients showed an objective response. This combination appears to produce useful remissions in patients with non-squamous lung cancer.
MeSH terms
-
Carcinoma, Bronchogenic / drug therapy*
-
Doxorubicin / therapeutic use*
-
Drug Therapy, Combination
-
Female
-
Fluorouracil / therapeutic use*
-
Humans
-
Leucovorin / therapeutic use
-
Lung Neoplasms / drug therapy*
-
Male
-
Methotrexate / therapeutic use*
-
Middle Aged
-
Remission, Spontaneous
-
Time Factors
Substances
-
Doxorubicin
-
Leucovorin
-
Fluorouracil
-
Methotrexate